510(k) K953221
K953221 is an FDA 510(k) premarket notification submitted by Abbott Laboratories for the device "ABBOTT VISION HEMOGLOBIN (MODIFICATION)". The FDA issued a decision of Substantially Equivalent on September 29, 1995. The device falls under product code KHG (Whole Blood Hemoglobin Determination), a Class II device regulated under 21 CFR 864.7500. Abbott Laboratories has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 29, 1995
- Date Received
- June 19, 1995
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Whole Blood Hemoglobin Determination
- Device Class
- Class II
- Regulation Number
- 864.7500
- Review Panel
- HE
- Submission Type